ESC Professional Premium Access

Risk of thromboembolic and bleeding events in patients with atrial fibrillation after valvular intervention in either aortic or mitral position

Congress Presentation

About the speaker

Mrs Ebba-Louise Skogseid

Uppsala University, Uppsala (Sweden)
1 presentation
0 follower

6 more presentations in this session

Safety and efficacy of protamine administration for prevention of bleeding complications in patients with recent PCI undergoing TAVR

Speaker: Doctor B. Al-Kassou (Bonn, DE)

Thumbnail

Clinical outcomes in patients receiving oral anticoagulation stratified by the presence of dose reduction criteria and older age: a subanalysis of ENVISAGE-TAVI AF

Speaker: Professor N. van Mieghem (Rotterdam, NL)

Thumbnail

Anticoagulatory treatment and clinical outcomes after transcatheter aortic valve implantation: results from 45,598 patients of the German Aortic Valve Registry (GARY)

Speaker: Doctor C. Hohmann (Cologne, DE)

Thumbnail

Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study

Speaker: Mr J. Lehto (Turku, FI)

Thumbnail

Efficacy of aortic valve replacement on Heyde syndrome-related acquired von Willebrand syndrome and gastrointestinal bleeding: a systematic review and meta-analysis

Speaker: Mr M. Rooijakkers (Nijmegen, NL)

Thumbnail

Access the full session

Walking the line between bleeding and thrombosis in valvular heart disease

Speakers: Mrs E. Skogseid, Doctor B. Al-Kassou, Professor N. van Mieghem, Doctor C. Hohmann, Mr J. Lehto...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations